Therapeutic Goods Administration

Part of the Health portfolio and a Federal authority, also called TGA

The Therapeutic Goods Administration is responsible for regulating therapeutic goods including medicines, medical devices, blood and blood products.

71 requests
Make a request to this authority

(page 3)

License products: opioid medicines
Response by Therapeutic Goods Administration to Georgia Richards on .

Successful.

Dear Ms Richards   Thank you for your FOI request of 6 May 2019.   We recommend you search the Australian Register of Therapeutic Goods (ARTG)...
Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor, April 2001–October 2001 and October 2001–May 2002
Response by Therapeutic Goods Administration to Scott McCormick on .

Information not held.

Dear Mr McCormick   Please find attached correspondence in relation to your Freedom of Information request.   If you have any questions, pleas...
Adverse event reports for mefloquine hydrochloride ('Lariam') between 1980 ans 2018
Response by Therapeutic Goods Administration to Jane Quinn on .

Successful.

Dear Dr Quinn   Please find attached correspondence in relation to your Freedom of Information request.   If you have any questions, please do...
Information related to the NCE approval of tafenoquine succinate
Response by Therapeutic Goods Administration to Jane Quinn on .

Partially successful.

Dear Dr Quinn   I am resending the email below as we received an email stating that there was an issue delivering the email.   Kind regards...
Pre-registration and registration application information pertaining to the registration of tafenoquine succinate.
Response by Therapeutic Goods Administration to Jane Quinn on .

Refused.

Dear Miss Quinn, We refer to your email 17 April 2018 (copy below). We advise that the TGA does not utilise the right to know platform outlined in yo...
applications to import unapproved therapeutic goods under TGA's Special Access Scheme, 2015 to mid-2017
Request to Therapeutic Goods Administration by faustus. Annotated by faustus on .

Refused.

Noting the fees quoted in previous FOI attempts, I structured my request in a manner that would obviate any fees. Yet, in spite of this approach, I was...
Registration information and amendments to dosage of mefloquine ('Lariam')
Response by Therapeutic Goods Administration to Jane Quinn on .

Successful.

Dear Ms Quinn,   Please find attached the Notice of Decision in relation to your Freedom of Information request.   Kind regards   Freedom...
Documents Relating to Applications for the Registration of Tafenoquine for Malaria Chemoprophylaxis
Response by Therapeutic Goods Administration to Stuart McCarthy on .

Refused.

Dear Mr McCarthy,   Please find attached correspondence in relation to your FOI request.   Kind regards Jacki   Freedom of Information (...
Tafenoquine Adverse Event Notifications
Response by Therapeutic Goods Administration to Stuart McCarthy on .

Long overdue.

Dear Mr McCarthy   Please find attached correspondence in relation to your FOI request.   Kind regards Heather   Freedom of Information...
Therapeutic Goods Administration Approvals for Australian Defence Force Use of Tafenoquine in Bougainville and Timor Leste, 1999-2001
Response by Therapeutic Goods Administration to Stuart McCarthy on .

Long overdue.

Our reference: RQ17/00727 Agency reference: FOI 13937     Mr Stuart McCarthy By email: [FOI #1916 email]   Dear Mr McCarthy Extension o...
TGA Approvals for Australian Defence Force Use of Mefloquine in Townsville (Queensland) and Somalia, 1992-93
Response by Therapeutic Goods Administration to Stuart McCarthy on .

Information not held.

Dear Mr McCarthy   Please find attached correspondence in relation to your Freedom of Information request.   If you have any questions, please...
LIES
Follow up sent to Therapeutic Goods Administration by Rod Hamblin (Account suspended) on .

Awaiting internal review.

GET STUFFED Yours sincerely, Rod Hamblin
Documents Relating to Applications for the Registration of Tafenoquine for Malaria Prophylaxis
Request to Therapeutic Goods Administration by Stuart McCarthy. Annotated by Locutus Sum on .

Withdrawn by the requester.

It might have been easier if the applicant had just said that he was willing to give the agency an extension of 14 days to process the application. The...
Therapeutic Goods Administration Approvals for Australian Defence Force Use of Tafenoquine in Clinical Trials, 1999-2000
Clarification sent to Therapeutic Goods Administration by Stuart McCarthy on .

Withdrawn by the requester.

Given that the documents requested in FOI222-1516 were provided yesterday and your advice that no additional documents to those already identified i...
Use of Proton Pump Inhibitors and H2 Antagonists (compounded or not) in the paediatric population from 1995 to 2015
Response by Therapeutic Goods Administration to Joanne Matthews on .

Information not held.

Dear Mrs Joanne Matthews   I refer to your request to the Pharmaceutical Benefits Advisory Committee and the Therapeutic Goods Administration for...
Those who have reported Adverse Effects to CHAMPIX
Request to Therapeutic Goods Administration by Rod Hamblin (Account suspended). Annotated by Kristof Wing on .

Long overdue.

Hey Rod, I appreciate what you are trying to do here are would like help you! It looks like you're after information relating to adverse events rel...
Original Request of "FOI 250-1314 - Indian Manufacturer Issues"
Response by Therapeutic Goods Administration to Kristof Wing on .

Refused.

Dear Mr Wing,   Please find attached correspondence relating to your Freedom of Information request 108-1415 received 7 November 2014.   Kind...
Regulatory actions against Ranbaxy Laboratories Ltd.
Response by Therapeutic Goods Administration to Kristof Wing on .

Refused.

Dear Mr Wing,   Please find attached correspondence relating to your Freedom of Information request 091-1415 received 28 October 2014.   Kind...
Decision relating to Apotex, manufacturer of generic medications.
Response by Therapeutic Goods Administration to Tim Senior on .

Refused.

Dear Mr Senior,   Please find attached correspondence relating to your Freedom of Information Request 087-1415 received 27 October 2014.   Kin...
Communications relating to Sun Pharmaceuticals
Response by Therapeutic Goods Administration to Kristof Wing on .

Waiting clarification.

Dear Mr Wing   I am following up on the below email sent to you on 28 November.   The TGA would be very grateful if you could please provide a...
Documents relating to the classification of 'Piracetam' as a Schedule 4 poison
Response by Therapeutic Goods Administration to Oz on .

Withdrawn by the requester.

Dear Oz Please find attached correspondence in relation to your FOI request. If you have any questions please do not hesitate to contact me. Kind...

Only requests made using Right to Know are shown. ?